1 day ago · As of May 11, 2023, the average one-year price target for Ironwood Pharmaceuticals Inc - is 13.
2 days ago · Ironwood Pharmaceuticals plans to buy a Swiss biotech for $1 billion as the Boston drug firm seeks to strengthen its focus on treatments for gastrointestinal diseases.
(IRWD), a GI-focused healthcare company, announced Wednesday the appointment of Sravan Emany as senior. Jun 7, 2021 · – Thomas McCourt named permanent CEO and appointed to Ironwood Board of Directors – – Gina Consylman to step down as SVP, CFO effective July 2, 2021 – Ironwood Pharmaceuticals, Inc.
2 days ago · Ironwood Pharmaceuticals Inc said on Monday it would buy Switzerland-based drug developer VectivBio Holding AG for $1.
2 days ago · Tom McCourt is the CEO of Ironwood Pharmaceuticals.
2 days ago · Ironwood Pharmaceuticals (IRWD 3. . .
(RTTNews) - Ironwood Pharmaceuticals, Inc.
announced today that Tom Graney, chief financial officer and senior vice president, finance and corporate strategy will leave the.
announced that Gina Consylman plans to step down as chief financial officer, effective July 2, 2021, in order to pursue another leadership opportunity at a rare disease.
By Rowan Walrath – Life Sciences Reporter, Boston Business Journal.
. . May 22, 2023.
from June 2014 to December 2, 2017. BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. 2 days ago · Ironwood Pharmaceuticals (IRWD 3. . --(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotechnology company, today announced the appointment of William Huyett as chief operating officer and the promotion of Gina Consylman to senior vice president and chief financial officer.
– Thomas McCourt named permanent CEO and appointed to Ironwood Board of Directors –.
Ironwood Pharmaceuticals, Inc.
VP, Chief Legal Officer & Sec.